Mixed Urinary Incontinence
14
3
4
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
1 terminated out of 14 trials
75.0%
-11.5% vs benchmark
14%
2 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (14)
Implantation of an Adjustable Suburethral Sling is an Effective Treatment Method for Patients With Mixed Urinary Incontinence of Moderate to Severe Severity, After Which the Severity of the Stress and Urgency Components is Reduced.
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
Assessment of Platelet Rich Plasma Injection in Managing Female Patients Complaining of Mixed Urinary Incontinence (PRP)
Pharmacological vs Surgical Treatment for Mixed Incontinence
The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence
Electroacupuncture vs Sham Electrocupuncture for Mixed Urinary Incontinence
Electroacupuncture and Solifenacin for Urgency-predominant Mixed Urinary Incontinence
Acupuncture for Stress-predominant Mixed Urinary Incontinence
Comparing Use of a Digital Health System of Pelvic Floor Exercise Program to Kegel Exercises in Stress Urinary Incontinence
Translation and Validation of MESA Questionnaire of Chinese Language Version
Pelvic Floor Muscle Training With Leva System for Urge Incontinence
Urinary Urinary Nerve Growth Factor (NGF) as a Biomarker for Mixed Urinary Incontinence